(571 - Kb)

: To provide Congress with transparent data on the FDA's progress in managing the "backlog" of postmarketing studies that drug companies are required or have committed to conduct after a drug is approved.

Could you clarify if you are looking for specific data from the or one of the other entities? Postmarketing Requirements and Commitments: Reports - FDA (571 KB)

: Studies are categorized into "Pending" (not yet started), "Ongoing" (study underway), "Delayed" (behind the original schedule), or "Terminated/Released" (no longer required). : To provide Congress with transparent data on

: The FDA generally reports a steady decrease in the total number of open backlog files as studies are completed or closed. : The FDA generally reports a steady decrease

This report is part of a series provided to Congress regarding the status of postmarketing requirements (PMRs) and postmarketing commitments (PMCs). Below is a summary based on the standard contents of these annual FDA backlog reports:

: Mitsubishi Heavy Industries (MHI) lists a Corporate Governance report as part of its Integrated Report library with a size of 571 KB.